Evidence map›Paper›PMID 16127051›Full record

ArticleAntimicrobial agents and chemotherapy2005

Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.

Alok Mulky, John C Kappes

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alok MulkyUniversity of Alabama at Birmingham, Department of Microbiology, LHRB 613, 701 South 19th Street, Birmingham, AL 35294, USA.
John C Kappes
Birmingham VA Medical Center · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
ANALYSIS OF INTEGRASE IN REVERSE TRANSCRIPTIONR01AI047714 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KAPPES, JOHN C · 2000 to 2003
$998k
TRANSCOMPLEMENTATION SYSTEM TO STUDY PROVIRUS SYNTHESISR01CA073470 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KAPPES, JOHN C · 1997 to 2000
$227k
NCI NIH HHS CA73470NIAID NIH HHS AI47714NIAID NIH HHS P30 AI027767NIAID NIH HHS P30-AI-27767NIAID NIH HHS R01 AI047714
6 · The paper itself

Abstract

The reverse transcriptase (RT) of all retroviruses is required for synthesis of the viral DNA genome. The human immunodeficiency virus type 1 (HIV-1) RT exists as a heterodimer made up of 51-kDa and 66-kDa subunits. The crystal structure and in vitro biochemical analyses indicate that the p66 subunit of RT is primarily responsible for the enzyme's polymerase and RNase H activities. Since both the p51 and p66 subunits are generated from the same coding region, as part of the Pr160(Gag-Pol) precursor protein, there are inherent limitations for studying subunit-specific function with intact provirus in a virologically relevant context. Our lab has recently described a novel system for studying the RT heterodimer (p51/p66) wherein a LTR-vpr-p51-IRES-p66 expression cassette provided in trans to an RT-deleted HIV-1 genome allows precise molecular analysis of the RT heterodimer. In this report, we describe in detail the specific approaches, alternative strategies, and pitfalls that may affect the application of this novel assay for analyzing RT subunit structure/function in infectious virions and human target cells. The ability to study HIV-1 RT subunit structure/function in a physiologically relevant context will advance our understanding of both RT and the process of reverse transcription. The study of antiretroviral drugs in a subunit-specific virologic context should provide new insights into drug resistance and viral fitness. Finally, we anticipate that this approach will help elucidate determinants that mediate p51-p66 subunit interactions, which is essential for structure-based drug design targeting RT heterodimerization.

Indexed as

Blotting, WesternCell LineGenetic Complementation TestHIV-1HIV Reverse TranscriptaseHumansPlasmidsReverse Transcriptase InhibitorsStructure-Activity RelationshipTransfectionVirus IntegrationHIV Reverse TranscriptaseReverse Transcriptase Inhibitors

Identifiers

PMID16127051
PMCPMC1195396
OpenAlexW2125592759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.